3-iodo-2-hydroxy-6-methoxy-n-((1-ethyl-2-pyrrolidinyl)methyl)benzamide has been researched along with Cancer of Pituitary in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 5 (83.33) | 18.2507 |
| 2000's | 1 (16.67) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| de Herder, WW; Feelders, RA; Krenning, EP; Kwekkeboom, DJ; Reijs, AEM; van Aken, MO; van der Lely, AJ | 1 |
| D'Angelo, V; Di Fazio, P; Dicembrino, F; Liuzzi, A; Scarabino, T; Scillitani, A; Vettori, PP | 1 |
| de Herder, WW; Hofland, LJ; Krenning, EP; Kwekkeboom, DJ; Lamberts, SW; Nobels, FR; Oei, HY; Reijs, AE | 1 |
| Acampa, W; Cerbone, G; Colao, A; Ferone, D; Lastoria, S; Lombardi, G; Merola, B; Salvatore, M; Varrella, P | 1 |
| de Herder, WW; de Swart, J; Kaandorp, Y; Krenning, EP; Kwekkeboom, DJ; Lamberts, SW; Reijs, AE | 1 |
| Ambrosio, G; Battista, C; Cascini, GL; Mansi, L; Panza, N; Rambaldi, PF; Schillirò, F | 1 |
1 review(s) available for 3-iodo-2-hydroxy-6-methoxy-n-((1-ethyl-2-pyrrolidinyl)methyl)benzamide and Cancer of Pituitary
| Article | Year |
|---|---|
Diagnostic imaging of dopamine receptors in pituitary adenomas.
Topics: Adenoma; Benzamides; Dopamine Antagonists; Humans; Pituitary Neoplasms; Positron-Emission Tomography; Pyrrolidines; Receptors, Dopamine D2; Tomography, Emission-Computed, Single-Photon | 2007 |
1 trial(s) available for 3-iodo-2-hydroxy-6-methoxy-n-((1-ethyl-2-pyrrolidinyl)methyl)benzamide and Cancer of Pituitary
| Article | Year |
|---|---|
Correlation of scintigraphic results using 123I-methoxybenzamide with hormone levels and tumor size response to quinagolide in patients with pituitary adenomas.
Topics: Adenoma; Aminoquinolines; Benzamides; Biomarkers; Dopamine Agonists; Glycoprotein Hormones, alpha Subunit; Human Growth Hormone; Humans; Insulin-Like Growth Factor I; Iodine Radioisotopes; Magnetic Resonance Imaging; Pituitary Neoplasms; Prolactin; Pyrrolidines; Tomography, Emission-Computed, Single-Photon | 1998 |
4 other study(ies) available for 3-iodo-2-hydroxy-6-methoxy-n-((1-ethyl-2-pyrrolidinyl)methyl)benzamide and Cancer of Pituitary
| Article | Year |
|---|---|
In vivo visualization of pituitary dopaminergic receptors by iodine-123 methoxybenzamide (IBZM) correlates with sensitivity to dopamine agonists in two patients with macroprolactinomas.
Topics: Adult; Benzamides; Brain; Bromocriptine; Female; Humans; Iodine Radioisotopes; Magnetic Resonance Imaging; Magnetic Resonance Spectroscopy; Male; Pituitary Gland; Pituitary Neoplasms; Prolactin; Prolactinoma; Pyrrolidines; Receptors, Dopamine; Sensitivity and Specificity; Tomography, Emission-Computed, Single-Photon | 1995 |
In vivo imaging of pituitary tumours using a radiolabelled dopamine D2 receptor radioligand.
Topics: Adenoma; Adolescent; Adult; Aminoquinolines; Benzamides; Contrast Media; Dopamine Agonists; Dopamine Antagonists; Female; Growth Hormone; Humans; Male; Middle Aged; Pituitary Gland; Pituitary Neoplasms; Prolactin; Prolactinoma; Pyrrolidines; Receptors, Dopamine D2; Thyrotropin; Tomography, Emission-Computed, Single-Photon | 1996 |
Comparison of iodine-123 epidepride and iodine-123 IBZM for dopamine D2 receptor imaging in clinically non-functioning pituitary macroadenomas and macroprolactinomas.
Topics: Adenoma; Benzamides; Brain; Dopamine Antagonists; Female; Humans; Iodine Radioisotopes; Male; Middle Aged; Pituitary Neoplasms; Prolactinoma; Pyrrolidines; Radiopharmaceuticals; Receptors, Dopamine D2; Tomography, Emission-Computed, Single-Photon | 1999 |
Receptor imaging with 111In-pentreotide and 123I-methoxybenzamide, and inhibition tests with octreotide and bromocriptine of mixed growth hormone/prolactin-secreting pituitary tumors.
Topics: Adult; Benzamides; Bromocriptine; Contrast Media; Growth Hormone; Humans; Indium Radioisotopes; Iodine Radioisotopes; Magnetic Resonance Imaging; Male; Middle Aged; Octreotide; Pituitary Neoplasms; Prolactin; Pyrrolidines; Radionuclide Imaging; Tomography | 1999 |